Adrian F Hernandez Selected Research

Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)

1/2022	Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure: Analysis of the LIFE Trial Run-In.
1/2022	Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection Fraction.
1/2021	Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities.
1/2021	Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction.
10/2020	Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial.
1/2019	Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry.
1/2019	Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.
12/2018	Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF Trial.
1/2018	Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States.
1/2018	Timing of Postdischarge Follow-Up and Medication Adherence Among Patients With Heart Failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrian F Hernandez Research Topics

Disease

369	Heart Failure 05/2024 - 01/2004
61	Stroke (Strokes) 03/2024 - 09/2009
42	Myocardial Infarction 04/2024 - 10/2005
41	Ischemic Stroke 01/2023 - 05/2010
40	Atrial Fibrillation 12/2022 - 08/2008
39	Type 2 Diabetes Mellitus (MODY) 05/2024 - 04/2016
34	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2016
23	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023 - 11/2007
22	Hemorrhage 02/2024 - 11/2011
21	Dyspnea (Shortness of Breath) 01/2023 - 02/2009
19	Cardiomyopathies (Cardiomyopathy) 05/2024 - 05/2005
18	Diabetes Mellitus 09/2023 - 03/2012
17	Chronic Renal Insufficiency 04/2024 - 08/2011
17	Venous Thromboembolism 02/2023 - 03/2014
15	COVID-19 11/2023 - 01/2020
13	Left Ventricular Dysfunction 04/2024 - 12/2008
13	Hypotension (Low Blood Pressure) 03/2024 - 11/2010
10	Acute Coronary Syndrome 01/2022 - 12/2007
10	Renal Insufficiency (Renal Failure) 01/2019 - 10/2008
9	Iron Deficiencies 01/2024 - 01/2016
9	Heart Diseases (Heart Disease) 01/2023 - 09/2016
9	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018 - 03/2012
8	Infections 09/2023 - 08/2015
8	Thrombosis (Thrombus) 02/2023 - 09/2010
8	Weight Loss (Weight Reduction) 11/2022 - 11/2010
7	Transient Ischemic Attack 03/2024 - 09/2009
7	Coronary Disease (Coronary Heart Disease) 01/2024 - 09/2006
7	Hypertension (High Blood Pressure) 12/2023 - 09/2009
7	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023 - 06/2012
7	ST Elevation Myocardial Infarction 06/2018 - 08/2009
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2024 - 05/2011
6	Peripheral Arterial Disease 01/2023 - 01/2014
6	Edema (Dropsy) 01/2023 - 11/2010
6	Inflammation (Inflammations) 01/2023 - 01/2015
6	Fibrosis (Cirrhosis) 01/2021 - 01/2014
5	Chronic Obstructive Pulmonary Disease (COPD) 03/2024 - 01/2010
5	Pneumonia (Pneumonitis) 10/2022 - 11/2013
5	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022 - 09/2006

Drug/Important Bio-Agent (IBA)

68	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 12/2007
49	dapagliflozinIBA 05/2024 - 01/2020
29	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 12/2008
25	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 02/2011
24	vericiguatIBA 01/2024 - 01/2018
24	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2009
24	Mineralocorticoid Receptor AntagonistsIBA 12/2022 - 08/2008
24	Angiotensin Receptor AntagonistsIBA 01/2022 - 12/2008
23	sacubitril and valsartan sodium hydrate drug combinationIBA 03/2024 - 10/2016
23	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2024 - 01/2010
22	DiureticsIBA 11/2023 - 11/2010
21	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 03/2013
19	Warfarin (Coumadin)FDA LinkGeneric 10/2019 - 02/2009
18	Neprilysin (Neutral Endopeptidase)IBA 03/2024 - 01/2016
18	Exenatide (Byetta)FDA Link 05/2023 - 04/2016
17	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2024 - 09/2012
17	SodiumIBA 02/2024 - 01/2010
16	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 10/2019
16	betrixabanIBA 02/2023 - 03/2014
15	CreatinineIBA 03/2024 - 09/2006
14	AnticoagulantsIBA 01/2022 - 11/2011
14	LipidsIBA 01/2019 - 08/2009
13	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023 - 11/2010
11	Sodium-Glucose Transport ProteinsIBA 05/2024 - 12/2019
11	Enoxaparin (Lovenox)FDA LinkGeneric 02/2023 - 11/2016
10	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 10/2019
10	Natriuretic PeptidesIBA 01/2023 - 09/2009
8	Glucagon-Like Peptide-1 ReceptorIBA 02/2024 - 04/2016
8	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2024 - 01/2018
8	omega-Chloroacetophenone (Mace)IBA 12/2023 - 07/2015
8	fibrin fragment D (D-dimer)IBA 02/2023 - 03/2017
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 04/2008
8	Vitamin K FDA Link 01/2023 - 05/2012
8	Hemoglobins (Hemoglobin)IBA 01/2022 - 03/2014
7	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 07/2014
7	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2020 - 03/2013
6	empagliflozinIBA 04/2024 - 01/2020
6	rGLP-1 proteinIBA 02/2024 - 01/2018
6	ferric carboxymaltoseIBA 01/2024 - 01/2021
6	Soluble Guanylyl CyclaseIBA 01/2023 - 12/2009
6	Valsartan (Vals)FDA Link 01/2023 - 10/2005
6	TroponinIBA 12/2018 - 11/2012
6	Urea (Carbamide)FDA LinkGeneric 06/2017 - 01/2010
6	NitrogenIBA 06/2017 - 01/2010
5	IronIBA 03/2024 - 01/2016
5	Furosemide (Lasix)FDA LinkGeneric 01/2023 - 03/2011
5	Hydralazine (Apresoline)FDA LinkGeneric 12/2019 - 02/2009

Therapy/Procedure

168	Therapeutics 05/2024 - 01/2004
32	Patient Readmission 01/2023 - 04/2008
25	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 05/2005
20	Length of Stay 01/2019 - 12/2008
14	Cardiac Resynchronization Therapy 01/2022 - 08/2008
13	Secondary Prevention 02/2024 - 10/2007
13	Heart-Assist Devices 10/2020 - 01/2004
11	Contraindications 01/2023 - 02/2009
9	Percutaneous Coronary Intervention 01/2022 - 08/2009
8	Thrombolytic Therapy 01/2022 - 02/2014
6	Drug Therapy (Chemotherapy) 01/2023 - 09/2012
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 08/2009
6	Heart Transplantation (Grafting, Heart) 01/2018 - 11/2005
5	Surgical Amputation (Amputations) 01/2023 - 01/2014
5	Defibrillators (Defibrillator) 01/2022 - 11/2014